Works matching IS 13518216 AND DT 2018 AND VI 24 AND IP 5
Results: 34
Congenital coagulation factor X deficiency: Genetic analysis of five patients and functional characterization of mutant factor X proteins.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 774, doi. 10.1111/hae.13606
- By:
- Publication type:
- Article
Efficacy and safety of low‐dose prophylaxis of highly purified plasma‐derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e387, doi. 10.1111/hae.13601
- By:
- Publication type:
- Article
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 766, doi. 10.1111/hae.13600
- By:
- Publication type:
- Article
Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e383, doi. 10.1111/hae.13598
- By:
- Publication type:
- Article
Evaluating the thrombin generation profiles of four different rFVIII products in FVIII‐deficient plasma using FIXa and FXIa activation.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 815, doi. 10.1111/hae.13597
- By:
- Publication type:
- Article
Real‐world comparative analysis of bleeding complications and health‐related quality of life in patients with haemophilia A and haemophilia B.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e322, doi. 10.1111/hae.13596
- By:
- Publication type:
- Article
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 726, doi. 10.1111/hae.13595
- By:
- Publication type:
- Article
Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
UK Haemophilia Centre Doctors’ Organisation guidance on the use of extended‐half‐life coagulation factor concentrates in routine clinical practice: Report of a meeting on their adoption by Belgian haemophilia treaters.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Application of optimized nursing process to perioperative patients with haemophilic pseudotumours.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Impact of target joint and FVIII inhibitor οn bone properties in children with haemophilia A: A peripheral quantitative computed tomography study.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 800, doi. 10.1111/hae.13591
- By:
- Publication type:
- Article
The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Value of prophylaxis vs on‐demand treatment: Application of a value framework in hemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 755, doi. 10.1111/hae.13589
- By:
- Publication type:
- Article
Positioning extended half‐life concentrates for future use: a practical proposal.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Desmopressin in non‐severe haemophilia A: Test‐response and clinical outcomes in a single Canadian centre review.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 720, doi. 10.1111/hae.13586
- By:
- Publication type:
- Article
Risk factors for cardiovascular disease in children and young adults with haemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 747, doi. 10.1111/hae.13585
- By:
- Publication type:
- Article
Review of molecular mechanisms at distal Xq28 leading to balanced or unbalanced genomic rearrangements and their phenotypic impacts on hemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 711, doi. 10.1111/hae.13569
- By:
- Publication type:
- Article
Effectiveness of a comprehensive educational programme for Accredited Social Health Activists (ASHAs) to identify individuals in the Udupi district with bleeding disorders: A community‐based survey.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 741, doi. 10.1111/hae.13567
- By:
- Publication type:
- Article
Potency estimates for recombinant factor IX in the one‐stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagent.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e363, doi. 10.1111/hae.13556
- By:
- Publication type:
- Article
Clinical and radiologic results after open‐wedge high tibial osteotomy in haemophilic knee arthropathy with varus deformity.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 792, doi. 10.1111/hae.13566
- By:
- Publication type:
- Article
Factor VIII activity of BAY 94‐9027 is accurately measured with most commonly used assays: Results from an international laboratory study.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 823, doi. 10.1111/hae.13564
- By:
- Publication type:
- Article
Clinical relevance of 3D gait analysis in patients with haemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 703, doi. 10.1111/hae.13563
- By:
- Publication type:
- Article
BAY 94‐9027, a PEGylated recombinant factor VIII, exhibits a prolonged half‐life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 733, doi. 10.1111/hae.13561
- By:
- Publication type:
- Article
Clinical outcomes and patient satisfaction following total hip and knee arthroplasty in patients with inherited bleeding disorders: A 20‐year single‐surgeon cohort.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 786, doi. 10.1111/hae.13559
- By:
- Publication type:
- Article
Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non‐haemophilic patients.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 807, doi. 10.1111/hae.13565
- By:
- Publication type:
- Article
In silico and in vitro immunogenicity assessment of B‐domain‐modified recombinant factor VIII molecules.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e354, doi. 10.1111/hae.13555
- By:
- Publication type:
- Article
Recommendations on multidisciplinary management of elective surgery in people with haemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 693, doi. 10.1111/hae.13549
- By:
- Publication type:
- Article
Emotional distress in haemophilia: Factors associated with the presence of anxiety and depression symptoms among adults.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e344, doi. 10.1111/hae.13548
- By:
- Publication type:
- Article
Long‐term outcomes from prophylactic or episodic treatment of haemophilia A: A systematic review.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e301, doi. 10.1111/hae.13546
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- 2018
- Publication type:
- Table of Contents
Instructions for Authors.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 833, doi. 10.1111/hae.13340
- Publication type:
- Article
Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e312, doi. 10.1111/hae.13543
- By:
- Publication type:
- Article
Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic‐guided prophylaxis based on Bayesian models with myPKFiT<sup>®</sup>.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e338, doi. 10.1111/hae.13540
- By:
- Publication type:
- Article
The Japanese Immune Tolerance Induction (J‐ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. e328, doi. 10.1111/hae.13531
- By:
- Publication type:
- Article